New Release: Alpha testing version has been released.

Diosmin

C05C - Capillary stabilizing agents ATC C05CA03 Small molecule Natural product Withdrawn Black-box warning

JFDA label: Diovenor Tab

⚠ Black-Box Warning
  • Drug Withdrawn from Market — ChEMBL drug_warning (Withdrawn) | Spain | unfavourable risk-benefit profile

Mechanism of Action

— Unknown

Indications

Approved

  • Cardiovascular Diseases — cardiovascular disease

Off-label

  • Arthritis, Rheumatoid
  • Colitis, Ulcerative
  • Infertility
  • Non-alcoholic Fatty Liver Disease
  • Peptic Ulcer
  • Venous Insufficiency

Contraindications

Source: openFDA

  • Do not use if you have a known allergy to any of the ingredients in Bruselix™ Bruising Tablets , including Arnica Montana or pineapple (Bromelain). Avoid use if you have an allergy to citrus or bioflavonoid components. Absolute

Dosing

Source: openFDA

Take one (1) Bruselix™ Bruising Tablets daily, or as directed by a licensed healthcare practitioner. Do not exceed recommended dose.

Warnings & Precautions

Source: openFDA

Warnings & Precautions

Arnica: May cause allergic reactions in sensitive individuals, especially if there is a history of ragweed allergies. Bromelain: May increase the risk of bleeding in individuals taking anticoagulants or antiplatelet medications. Discontinue use two weeks before surgery. Zinc and Vitamin C: Use cautiously in individuals with kidney disease or those prone to kidney stones. If you experience an allergic reaction or prolonged bleeding, discontinue use and seek medical attention immediately. For use on the order of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873.

Chemistry & Properties

2D structure
FormulaC28H32O15
Molecular weight608.55 g/mol
IUPAC name5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
CAS520-27-4
PubChem CID5281613
InChIKeyGZSOSUNBTXMUFQ-YFAPSIMESA-N
logP-1.09 (XLogP -0.8)
Polar surface area238.2 Ų
H-bond acceptors / donors15 / 8
Drug-likeness (QED)0.16
Lipinski violations3
SMILESCOc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O

Biology & Pharmacokinetics

Pharmacokinetics

BBB penetrantNo

Enzyme interactions

EnzymeRoleDetail
CYP2C8Inhibitor

Transporters

BCRP (Inhibitor)BSEP (Inhibitor)MDR1 (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)

Registered Products (2)

BrandForm / strengthPackAgentCitizen (JOD)
Diosper Tab Tablet 450 mg, 50 mg 30 tab AL Rahma Drug Store 3.140
Diovenor Tab Tablet 600 mg 30 tab Quality Drug Store 9.100